The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 6373-6383

  Catalano, Alfonso ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 17; NEUROPILIN 1; PLASMID DNA; SEMAPHORIN 3A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SEPARATION; CYTOKINES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MICE; MICE, INBRED DBA; NEUROPILIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEMAPHORIN-3A; T-LYMPHOCYTE SUBSETS;

EID: 78650632039     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903527     Document Type: Article

References (34)

1. Pasterkamp, R. J., and A. L. Kolodkin. 2003. Semaphorin junction: making tracks toward neural connectivity. Curr. Opin. Neurobiol. 13:79-89.
2. Tamagnone, L., S. Artigiani, H. Chen, Z. He, G. I. Ming, H. Song, A. Chedotal, M. L. Winberg, C. S. Goodman, M. Poo, et al. 1999. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99:71-80.
3. Toyofuku, T., H. Zhang, A. Kumanogoh, N. Takegahara, M. Yabuki, K. Harada, M. Hori, and H. Kikutani. 2004. Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat. Cell Biol. 6:1204-1211.
4. Tamagnone, L., and P. M. Comoglio. 2004. To move or not to move? Semaphorin signalling in cell migration. EMBO Rep. 5:356-361.
5. Carmeliet, P., and M. Tessier-Lavigne. 2005. Common mechanisms of nerve and blood vessel wiring. Nature 436:193-200.
6. Serini, G., D. Valdembri, S. Zanivan, G. Morterra, C. Burkhardt, F. Caccavari, L. Zammataro, L. Primo, L. Tamagnone, M. Logan, et al. 2003. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424:391-397.
7. Acevedo, L. M., S. Barillas, S. M. Weis, J. R. Göthert, and D. A. Cheresh. 2008. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 111:2674-2680.
8. Valdembri, D., P. T. Caswell, K. I. Anderson, J. P. Schwarz, I. König, E. Astanina, F. Caccavari, J. C. Norman, M. J. Humphries, F. Bussolino, and G. Serini. 2009. Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS Biol. 7: e25.
9. Guttmann-Raviv, N., N. Shraga-Heled, A. Varshavsky, C. Guimaraes-Sternberg, O. Kessler, and G. Neufeld. 2007. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem. 282:26294-26305.
10. Kaneko, S., A. Iwanami, M. Nakamura, A. Kishino, K. Kikuchi, S. Shibata, H. J. Okano, T. Ikegami, A. Moriya, O. Konishi, et al. 2006. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat. Med. 12:1380-1389.
11. Sierra, J. R., S. Corso, L. Caione, V. Cepero, P. Conrotto, A. Cignetti, W. Piacibello, A. Kumanogoh, H. Kikutani, P. M. Comoglio, et al. 2008. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumorassociated macrophages. J. Exp. Med. 205:1673-1685.
12. Rolny, C., L. Capparuccia, A. Casazza, M. Mazzone, A. Vallario, A. Cignetti, E. Medico, P. Carmeliet, P. M. Comoglio, and L. Tamagnone. 2008. The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment. J. Exp. Med. 205:1155-1171.
13. Futamura, M., H. Kamino, Y. Miyamoto, N. Kitamura, Y. Nakamura, S. Ohnishi, Y. Masuda, and H. Arakawa. 2007. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. Cancer Res. 67:1451-1460.
14. Sekido, Y., S. Bader, F. Latif, J. Y. Chen, F. M. Duh, M. H. Wei, J. P. Albanesi, C. C. Lee, M. I. Lerman, and J. D. Minna. 1996. Human semaphorins A (V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc. Natl. Acad. Sci. USA 93:4120-4125.
15. Vacca, A., C. Scavelli, G. Serini, G. di Pietro, T. Cirulli, F. Merchionne, D. Ribatti, F. Bussolino, D. Guidolin, G. Piaggio, et al. 2006. Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 108:1661-1667.
16. Maione, F., F. Molla, C. Meda, R. Latini, L. Zentilin, M. Giacca, G. Seano, G. Serini, F. Bussolino, and E. Giraudo. 2009. Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J. Clin. Invest. 119:3356-3372.
17. Kikutani, H., and A. Kumanogoh. 2003. Semaphorins in interactions between T cells and antigen-presenting cells. Nat. Rev. Immunol. 3:159-167.
18. Suzuki, K., A. Kumanogoh, and H. Kikutani. 2008. Semaphorins and their receptors in immune cell interactions. Nat. Immunol. 9:17-23.
19. Catalano, A., P. Caprari, S. Moretti, M. Faronato, L. Tamagnone, and A. Procopio. 2006. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107:3321-3329.
20. Lepelletier, Y., I. C. Moura, R. Hadj-Slimane, A. Renand, S. Fiorentino, C. Baude, A. Shirvan, A. Barzilai, and O. Hermine. 2006. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur. J. Immunol. 36:1782-1793.
21. Lepelletier, Y., S. Smaniotto, R. Hadj-Slimane, D. M. Villa-Verde, A. C. Nogueira, M. Dardenne, O. Hermine, and W. Savino. 2007. Control of human thymocyte migration by Neuropilin-1/Semaphorin-3A-mediated interactions. Proc. Natl. Acad. Sci. USA 104:5545-5550.
22. Sarris, M., K. G. Andersen, F. Randow, L. Mayr, and A. G. Betz. 2008. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28:402-413.
23. Brennan, F. M., and I. B. McInnes. 2008. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118:3537-3545.
24. André, S., D. F. Tough, S. Lacroix-Desmazes, S. V. Kaveri, and J. Bayry. 2009. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. Am. J. Pathol. 174:1575-1587.
25. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927-930.
26. Medzhitov, R., and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298-300.
27. Catalano, A., P. Caprari, S. Rodilossi, P. Betta, M. Castellucci, A. Casazza, L. Tamagnone, and A. Procopio. 2004. Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J. 18:358-360.
28. Banu, N., J. Teichman, M. Dunlap-Brown, G. Villegas, and A. Tufro. 2006. Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J. 20:2150-2152.
29. Rabinovich, G. A., G. Daly, H. Dreja, H. Tailor, C. M. Riera, J. Hirabayashi, and Y. Chernajovsky. 1999. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 190:385-398.
30. Yang, L., D. E. Anderson, C. Baecher-Allan, W. D. Hastings, E. Bettelli, M. Oukka, V. K. Kuchroo, and D. A. Hafler. 2008. IL-21 and TGF-beta are required for differentiation of human T (H) 17 cells. Nature 454:350-352.
31. Miller, L. E., C. Weidler, W. Falk, P. Angele, J. Schaumburger, J. Schölmerich, and R. H. Straub. 2004. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 50:1156-1163.
32. Yamamoto, M., K. Suzuki, T. Okuno, T. Ogata, N. Takegahara, H. Takamatsu, M. Mizui, M. Taniguchi, A. Chédotal, F. Suto, et al. 2008. Plexin-A4 negatively regulates T lymphocyte responses. Int. Immunol. 20:413-420.
33. Tordjman, R., Y. Lepelletier, V. Lemarchandel, M. Cambot, P. Gaulard, O. Hermine, and P. H. Roméo. 2002. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat. Immunol. 3:477-482.
34. Taylor, P. C., and M. Feldmann. 2009. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat. Rev. Rheumatol 5:578-582.